Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies
US10017578B2 · kind B2 · utility
8Cited by
26References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2017 |
| Grant date | Jul 10, 2018 |
| Priority date | — |
| Expiry date | Mar 29, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention generally relates to antibodies that bind to human folate receptor and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are further provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.